By Deborah Levine Treasurys remained lower Thursday, pushing rates up for a second day, before the government is expected to announce a record $97...
The corporate bond market caught a huge gust of wind in its sails on Tuesday, as companies lined up to raise financing for everything from funding...
The corporate bond market caught a huge gust of wind in its sails on Tuesday, as companies lined up to raise financing for everything from...
The corporate bond market is catching a huge gust of wind in its sails on Tuesday, as companies are lining up in droves to raise financing for...
The European Medicines Agency Friday confirmed that marketing authorization for Zenapax, used to treat organ rejection, is being withdrawn in the...
The failure of its lead product candidate, Riquent, may be the end of the road for tiny biotech La Jolla Pharmaceutical Co. (LJPC) and may leave...
Roche Holding AG (RHHBY) decided to launch its $86.50-a-share tender offer for the 44% of Genentech Inc. (DNA) that it didn't already own after...
(Adds details and background throughout; comments from executives beginning in 3rd paragraph; updates stock price.) By Peter Loftus Of DOW JONES...
Roche Holding AG (RHHBY) Chief Executive Severin Schwan reiterated his confidence in acquiring the 44% of Genentech Inc. (DNA) that it doesn't...
(Adds details about new case of brain infection in Tysabri user beginning in 3rd paragraph; comments from executives beginning in 5th paragraph...
GlaxoSmithKline PLC (GSK) Thursday reported declining fourth-quarter earnings hit by extra charges, saying that it won't provide a specific...
Swiss pharmaceutical company Roche Holding AG (ROG.VX) Wednesday reported an 8% drop in full-year net profit and slightly lower sales, blaming the...
Swiss pharmaceutical company Roche Holding AG (ROG.VX) Wednesday reported an 8% drop in full-year net profit and slightly lower sales, sending...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.